Skip to content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

AAOA Member Benefits

  • Up to 60% discount for CME programs and free Annual Meeting. All AAOA’s CME programs meet ABOTOHNS Continuing Certification.
  • AAOA US ENT Affinity program, where AAOA members can gain savings on antigen, allergy supplies, and any of the other 5 service lines US ENT offers. For more email info@usentpartners.com.
  • Tools and resources to comply with US General Chapter 797 and practice management tools.
  • Advocacy support.
  • And much more! Learn More

ADVOCACY UPDATES

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

Read more

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

Read more

Additional COVID-19 Relief Up in the Air

House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…

Read more

Upcoming Dates

04/01/24: Fellow Exam Application Deadline
Learn more

06/01/24: Research Grant Cycle
Learn more

06/25/24: Membership Application Deadline to be eligible for AAOA Member rate for the 2024 Basic Course

08/02/24: Scientific Abstract Submission Deadline
Learn more

12/01/24: Research Grant Cycle
Learn more

EDUCATION

AAOA Advanced Course

The recorded course content is available until April 30, 2024. This year’s Advanced Course featured Laryngology and Skull Base Surgery with Nausheen Jamal, MD and Garret Choby, MD as featured faculty.

RESIDENTS

For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Content Access Deadline:
April 30, 2024
Learn More and Register

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Register

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More 

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - April 1, 2024

News and Updates

Call For Proposals

We want to hear from you! We are pleased to invite you to participate in…

Read more

National Study to Document Changes in Physician Practice Expense

The American Medical Association (AMA) is undertaking a new national study, supported by 173 healthcare organizations,…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Allergic Rhinitis and Nasal Sprays

As indicated in our mission statement, the AAOA is concerned with advancing the treatment of patients with allergic disease.  When the FDA was considering making Nasacort available over-the-counter, the AAOA surveyed our membership about the topic.

The biggest concerns expressed were ensuring patients were getting an accurate diagnosis of their nasal problems, were given good information about available treatment options, and that they were being monitored long-term for potential side effects of medications, such as nasal steroid sprays.

Nasal steroid sprays are a great treatment option for patients with allergic rhinitis. They are generally considered the most effective class of medications available for treating the four major symptoms of allergic rhinitis, particularly nasal obstruction, runny nose, nasal itching, and sneezing. Now that the FDA has approved the over-the-counter availability of Nasacort, we hope that this will make the nasal steroid treatment option more available and affordable for patients with allergic rhinitis. This is what happened after non-sedating antihistamines became available over-the-counter. The AAOA still stresses the importance of patients receiving a good assessment of their nasal problems to make sure the appropriate treatment options are recommended. If nasal steroid sprays appear to be a good option, for some patients it will be more affordable to buy these over-the-counter.  As of now, patients with prescription drug coverage often still get a better price on generic nasal steroid sprays by prescription, compared to purchasing them over-the-counter.  We still recommend the patients have regular examinations of their nose, typically at least once a year, to make sure there are no complications of persistent nasal steroid spray use.

With the approval of Nasacort, more nasal steroid sprays are likely to become available over the counter. The FDA has already approved the Flonase brand for over-the-counter availability. It has been reported online that Flonase will likely become available in stores over-the-counter in early 2015. As multiple nasal steroid sprays become available over-the-counter, it is possible generic brands will also become available, and hopefully competition will result in lower prices.

 

Back To Top